210 related articles for article (PubMed ID: 2817790)
21. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice.
Saegusa Y; Eriguchi M; Kidani Y; Matsuzawa A; Takeda Y
Anticancer Res; 2001; 21(1A):245-52. PubMed ID: 11299742
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
[TBL] [Abstract][Full Text] [Related]
24. Liposoluble platinum(II) complexes with antitumor activity.
Maeda M; Uchida NA; Sasaki T
Jpn J Cancer Res; 1986 Jun; 77(6):523-5. PubMed ID: 3015851
[TBL] [Abstract][Full Text] [Related]
25. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
[TBL] [Abstract][Full Text] [Related]
26. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of a new platinum compound (glycolate-o,o') diammineplatinum (II) (254-S), against non-small cell lung carcinoma grown in a human tumor clonogenic assay system.
Kanzawa F; Matsushima Y; Nakano H; Nakagawa K; Takahashi H; Sasaki Y; Saijo N
Anticancer Res; 1988; 8(3):323-7. PubMed ID: 2839098
[TBL] [Abstract][Full Text] [Related]
28. Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
Perez-Soler R; Khokhar AR; Lopez-Berestein G
Cancer Res; 1987 Dec; 47(24 Pt 1):6462-6. PubMed ID: 3315188
[TBL] [Abstract][Full Text] [Related]
29. Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.
Hacker MP; Khokhar AR; Krakoff IH; Brown DB; McCormack JJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6250-4. PubMed ID: 3779645
[TBL] [Abstract][Full Text] [Related]
30. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
Fujimoto S
Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.
Kido Y; Khokhar AR; Yoshida M; Thai GW; Siddik ZH
Drug Metab Dispos; 1994; 22(2):312-7. PubMed ID: 8013287
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems.
Flora KP; van't Riet B; Wampler GL
Cancer Res; 1978 May; 38(5):1291-5. PubMed ID: 639062
[TBL] [Abstract][Full Text] [Related]
33. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of cisplatin antitumour activity by Ethyldeshydroxy-Sparsomycin in L1210 leukemia.
Hofs HP; Wagener DJ; De Valk-Bakker V; Van Rennes H; Van Zeist AJ; Van Den Broek LA; Ottenheijm HC
Anticancer Res; 1992; 12(1):167-70. PubMed ID: 1567164
[TBL] [Abstract][Full Text] [Related]
35. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
36. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
37. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
38. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
Fujita F; Fujita M; Sakamoto Y; Taguchi T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):215-21. PubMed ID: 8382036
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor effect of a benzoylphenylurea derivative HO-221].
Nakajima T; Masuda H; Okamoto T; Watanabe M; Yokoyama K; Yamada N; Tsukagoshi S; Taguchi T
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2353-9. PubMed ID: 2260871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]